Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

NCT00538330 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tamoxifen

Sponsor

King Faisal Specialist Hospital & Research Center